Skip to content

Clinical trials

Drug Resistant Epilepsy trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Drug Resistant Epilepsy Country / region: United Kingdom Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20081
20121
20161
20172
20183
20192
20203
20211
20222
20243

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Terminated6
Unknown status3
Active, not recruiting1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Biohaven Therapeutics Ltd.3
LivaNova3
Great Ormond Street Hospital for Children NHS Foundation Trust2
PTC Therapeutics2
UCB Biopharma SRL2
Vitaflo International, Ltd2
Institute of Child Health1
MedtronicNeuro1
Nutricia UK Ltd1
SK Life Science, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Drug Resistant Epilepsy20
Epilepsy10
Seizures8
Epilepsies, Partial4
Diffuse Cerebral Sclerosis of Schilder2
Leigh Disease2
MELAS Syndrome2
MERRF Syndrome2
Epilepsy, Absence1
Epilepsy, Generalized1

Trials

Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.